SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE : revenue, balance sheet and financial ratios

SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE is a French company founded 16 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in VANNES (56000), this company of category PME shows in 2021 a revenue of 3 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE (SIREN 518993878)
Indicator 2024 2023 2021 2020 2018 2017 2016
Revenue N/C N/C 3 343 € N/C 3 309 914 € 3 269 861 € 3 335 149 €
Net income 26 090 € -117 042 € -9 601 € 275 683 € 219 154 € 195 122 € 221 098 €
EBITDA -7 655 € -6 420 € -16 970 € N/C 287 983 € 258 269 € 330 293 €
Net margin N/C N/C -287.2% N/C 6.6% 6.0% 6.6%

Revenue and income statement

In 2024, SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE generates positive net income of 26 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 221 k€ -> 26 k€.

EBITDA (2024) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-7 655 €

EBIT (2024) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-7 655 €

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

26 090 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 100%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

99.732%

Repayment capacity (2024) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

0.0

Solvency indicators evolution
SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE

Sector positioning

Debt ratio
0.0 2024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent

In 2024, the debt ratio of SPFPL DOMINIQUE CHARLES, ... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
99.73% 2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Excellent +21 pts over 3 years

In 2024, the financial autonomy of SPFPL DOMINIQUE CHARLES, ... (99.7%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
0.0 years 2024
2021
2023
2024
Q1: 0.52 years
Med: 3.19 years
Q3: 7.6 years
Excellent

In 2024, the repayment capacity of SPFPL DOMINIQUE CHARLES, ... (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 23740.51. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

23740.507

Interest coverage (2024) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.0

Liquidity indicators evolution
SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE

Sector positioning

Liquidity ratio
23740.51 2024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Excellent

In 2024, the liquidity ratio of SPFPL DOMINIQUE CHARLES, ... (23740.51) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Interest coverage
0.0x 2024
2021
2023
2024
Q1: 0.0x
Med: 2.35x
Q3: 7.73x
Average

In 2024, the interest coverage of SPFPL DOMINIQUE CHARLES, ... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 131 days. Excellent situation: suppliers finance 131 days of the operating cycle (retail model).

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

131 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE

Positioning of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 225 transactions of similar company sales in 2024, the value of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE is estimated at 364 235 € (range 253 647€ - 544 917€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2024
225 transactions
253k€ 364k€ 544k€
364 235 € Range: 253 647€ - 544 917€
NAF 5 année 2024

Valuation method used

Net Income Multiple
26 090 € × 14.0x = 364 236 €
Range: 253 648€ - 544 917€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE

What is the revenue of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE ?

The revenue of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE in 2021 is 3 k€.

Is SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE profitable?

Yes, SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE generated a net profit of 26 k€ in 2024.

Where is the headquarters of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE ?

The headquarters of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE is located in VANNES (56000), in the department Morbihan.

Where to find the tax return of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE ?

The tax return of SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE operate?

SPFPL DOMINIQUE CHARLES, PHARMACIEN D'OFFICINE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.